269 related articles for article (PubMed ID: 30516846)
21. HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1.
Schuller S; Sieker J; Riemenschneider P; Köhler B; Drucker E; Weiler SME; Dauch D; Sticht C; Goeppert B; Roessler S; Ribback S; Breuhahn K; Fend F; Dombrowski F; Singer K; Singer S
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053620
[TBL] [Abstract][Full Text] [Related]
22. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.
Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712
[TBL] [Abstract][Full Text] [Related]
23. Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.
Bárcena-Varela M; Caruso S; Llerena S; Álvarez-Sola G; Uriarte I; Latasa MU; Urtasun R; Rebouissou S; Alvarez L; Jimenez M; Santamaría E; Rodriguez-Ortigosa C; Mazza G; Rombouts K; San José-Eneriz E; Rabal O; Agirre X; Iraburu M; Santos-Laso A; Banales JM; Zucman-Rossi J; Prósper F; Oyarzabal J; Berasain C; Ávila MA; Fernández-Barrena MG
Hepatology; 2019 Feb; 69(2):587-603. PubMed ID: 30014490
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of the epigenetic regulator SETDB1 in liver carcinogenesis-more than one way to skin a cat.
Longerich T
Chin Clin Oncol; 2016 Dec; 5(6):72. PubMed ID: 27164857
[TBL] [Abstract][Full Text] [Related]
25. Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
Wang P; Song X; Cao D; Cui K; Wang J; Utpatel K; Shang R; Wang H; Che L; Evert M; Zhao K; Calvisi DF; Chen X
Cell Death Dis; 2020 Feb; 11(2):91. PubMed ID: 32019910
[TBL] [Abstract][Full Text] [Related]
26. Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression.
Shen J; Chen M; Lee D; Law CT; Wei L; Tsang FH; Chin DW; Cheng CL; Lee JM; Ng IO; Wong CC; Wong CM
Gut; 2020 Feb; 69(2):329-342. PubMed ID: 31439637
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
28. Tethering of Lsh at the Oct4 locus promotes gene repression associated with epigenetic changes.
Ren J; Hathaway NA; Crabtree GR; Muegge K
Epigenetics; 2018; 13(2):173-181. PubMed ID: 28621576
[TBL] [Abstract][Full Text] [Related]
29. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway.
Wang J; Zhang N; Han Q; Lu W; Wang L; Yang D; Zheng M; Zhang Z; Liu H; Lee TH; Zhou XZ; Lu KP
Cancer Lett; 2019 Mar; 444():82-93. PubMed ID: 30583078
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
31. Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma.
Kong LM; Yao L; Lu N; Dong YL; Zhang J; Wang YQ; Liu L; Zhang HL; Huang JG; Liao CG
Oncotarget; 2016 May; 7(19):27975-87. PubMed ID: 27057625
[TBL] [Abstract][Full Text] [Related]
32. The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation.
von Eyss B; Maaskola J; Memczak S; Möllmann K; Schuetz A; Loddenkemper C; Tanh MD; Otto A; Muegge K; Heinemann U; Rajewsky N; Ziebold U
EMBO J; 2012 Feb; 31(4):972-85. PubMed ID: 22157815
[TBL] [Abstract][Full Text] [Related]
33. An ATPase-deficient variant of the SNF2 family member HELLS shows altered dynamics at pericentromeric heterochromatin.
Lungu C; Muegge K; Jeltsch A; Jurkowska RZ
J Mol Biol; 2015 May; 427(10):1903-15. PubMed ID: 25823553
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma.
Sgro A; Cursons J; Waryah C; Woodward EA; Foroutan M; Lyu R; Yeoh GCT; Leedman PJ; Blancafort P
Clin Epigenetics; 2023 Apr; 15(1):73. PubMed ID: 37120619
[TBL] [Abstract][Full Text] [Related]
35. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
38. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis.
Liang X; Li L; Fan Y
Front Immunol; 2022; 13():870726. PubMed ID: 35774795
[TBL] [Abstract][Full Text] [Related]
40. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
